Increased 5‐HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations
- 23 July 2010
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 25 (10), 1399-1408
- https://doi.org/10.1002/mds.23083
Abstract
Well-formed visual hallucinations (VH) are common in patients with Parkinson's disease (PD). The pathophysiology of VH in PD is unknown but may involve structures mediating visual processing such as the inferior temporal cortex. Serotonergic type 2A (5-HT2A) receptors have been linked to many psychiatric disorders, including psychosis. We hypothesized that enhanced 5-HT2A receptor levels may be involved in VH in PD. Autoradiographic binding using [3H]-ketanserin and spiperone, to define 5-HT2A receptors, was performed in 6 PD patients with VH, 6 PD patients without VH, and 5 healthy, age-matched controls. The cerebral regions studied included the orbitofrontal cortex, inferolateral temporal cortex, motor cortex, striatum, and substantia nigra. There was a significant (45.6%) increase in the levels of [3H]-ketanserin binding in the inferolateral temporal cortex of PD patients with VH when compared with PD patients without VH (54.3 ± 5.2 fmol/mg vs. 37.3 ± 4.3 fmol/mg, P = 0.039). Additionally, there was a significant increase in the levels of 5-HT2A receptors in the motor cortex of all PD patients taken as a group when compared with controls (57.8 ± 5.7 fmol/mg vs. 41.2 ± 2.6 fmol/mg, P = 0.0297). These results suggest that enhanced 5-HT2A-mediated neurotransmission in the inferolateral temporal cortex, a critical structure in visual processing, might be associated with the development of VH in PD. Our results provide new insights into the pathophysiology of VH in PD and provide an anatomical basis to explain why compounds with 5-HT2A antagonist activity are effective at alleviating this debilitating complication. © 2010 Movement Disorder SocietyFunding Information
- Dean's New Staff Award (SHF)
- Cure Parkinson's Trust
- Krembil Foundation (JMB)
- Edmond J. Safra Philanthropic Foundation
- Parkinson Society Canada
- United Kingdom Parkinson's Disease Society Tissue Bank at Imperial College
This publication has 50 references indexed in Scilit:
- Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognitionBrain, 2009
- Activation, internalization, and recycling of the serotonin 2A receptor by dopamineProceedings of the National Academy of Sciences of the United States of America, 2006
- High-resolution imaging reveals highly selective nonface clusters in the fusiform face areaNature Neuroscience, 2006
- Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson?s diseaseJournal of Neural Transmission, 2004
- Direct activation by dopamine of recombinant human 5-HT1A receptors: Comparison with human 5-HT2C and 5-HT3 receptorsSynapse, 2003
- A review of the role of serotonin receptors in psychiatric disordersHuman Psychopharmacology: Clinical and Experimental, 2000
- Separate visual pathways for perception and actionTrends in Neurosciences, 1992
- [3H]Ketanserin Labels Serotonin 5-HT2 and α1-Adrenergic Receptors in Human Brain CortexJournal of Cardiovascular Pharmacology, 1987
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- ParkinsonismNeurology, 1967